BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22829690)

  • 1. Peroxisome proliferator-activated receptor-gamma expression in monocytes/macrophages from rheumatoid arthritis patients: relation to disease activity and therapy efficacy--a pilot study.
    Palma A; Sainaghi PP; Amoruso A; Fresu LG; Avanzi G; Pirisi M; Brunelleschi S
    Rheumatology (Oxford); 2012 Nov; 51(11):1942-52. PubMed ID: 22829690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
    Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN
    Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway.
    Oxer DS; Godoy LC; Borba E; Lima-Salgado T; Passos LA; Laurindo I; Kubo S; Barbeiro DF; Fernandes D; Laurindo FR; Velasco IT; Curi R; Bonfa E; Souza HP
    Lupus; 2011 May; 20(6):575-87. PubMed ID: 21415255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigment epithelium-derived factor induces interleukin-10 expression in human macrophages by induction of PPAR gamma.
    Yang SL; Chen SL; Wu JY; Ho TC; Tsao YP
    Life Sci; 2010 Jul; 87(1-2):26-35. PubMed ID: 20553736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
    Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
    Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
    Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
    Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced peroxisome proliferator-activated receptor-gamma expression in monocyte/macrophages from coronary artery disease patients and possible gender differences.
    Amoruso A; Bardelli C; Fresu LG; Palma A; Vidali M; Ferrero V; Ribichini F; Vassanelli C; Brunelleschi S
    J Pharmacol Exp Ther; 2009 Nov; 331(2):531-8. PubMed ID: 19644041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of human monocyte/macrophage activity by tocilizumab, abatacept and etanercept: An in vitro study.
    Obeng JA; Amoruso A; Camaschella GL; Sola D; Brunelleschi S; Fresu LG
    Eur J Pharmacol; 2016 Jun; 780():33-7. PubMed ID: 26997366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes.
    Ji JD; Cheon H; Jun JB; Choi SJ; Kim YR; Lee YH; Kim TH; Chae IJ; Song GG; Yoo DH; Kim SY; Sohn J
    J Autoimmun; 2001 Nov; 17(3):215-21. PubMed ID: 11712859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPARalpha/gamma and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes.
    Hua Y; Xue J; Sun F; Zhu L; Xie M
    Pharmacology; 2009; 83(1):18-25. PubMed ID: 18971601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study.
    Bongartz T; Coras B; Vogt T; Schölmerich J; Müller-Ladner U
    Rheumatology (Oxford); 2005 Jan; 44(1):126-9. PubMed ID: 15479756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
    Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
    Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma.
    Józkowicz A; Huk I; Nigisch A; Cisowski J; Weigel G; Dulak J
    Acta Biochim Pol; 2003; 50(3):677-89. PubMed ID: 14515149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nitric oxide-donating pravastatin, NCX 6550, inhibits cytokine release and NF-κB activation while enhancing PPARγ expression in human monocyte/macrophages.
    Amoruso A; Bardelli C; Fresu LG; Poletti E; Palma A; Federici Canova D; Zeng HW; Ongini E; Brunelleschi S
    Pharmacol Res; 2010 Nov; 62(5):391-9. PubMed ID: 20670683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages.
    Ringseis R; Schulz N; Saal D; Eder K
    J Nutr Biochem; 2008 Sep; 19(9):594-603. PubMed ID: 18155510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study.
    Amoruso A; Sola D; Rossi L; Obeng JA; Fresu LG; Sainaghi PP; Pirisi M; Brunelleschi S
    Pharmacol Res; 2016 May; 107():308-314. PubMed ID: 27045818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment.
    Wijngaarden S; van Roon JA; van de Winkel JG; Bijlsma JW; Lafeber FP
    Rheumatology (Oxford); 2005 Jun; 44(6):729-34. PubMed ID: 15757966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of peroxisome proliferator-activated receptor-γ agonists on the generation of microparticles by monocytes/macrophages.
    Neri T; Cordazzo C; Carmazzi Y; Petrini S; Balìa C; Stefanelli F; Amoruso A; Brunelleschi S; Breschi MC; Pedrinelli R; Paggiaro P; Celi A
    Cardiovasc Res; 2012 Jun; 94(3):537-44. PubMed ID: 22425902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway.
    Fan Y; Meng S; Wang Y; Cao J; Wang C
    Int J Mol Med; 2011 Apr; 27(4):607-15. PubMed ID: 21327328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.